Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.37 | N/A |
| PEG Ratio (TTM) | 0.09 | N/A |
| P/S Ratio (TTM) | 0.26 | N/A |
| P/B Ratio (TTM) | 0.78 | N/A |
| P/FCF Ratio (TTM) | 4.19 | N/A |
| Price to 5YR AVG Earnings Ratio | -21.02 | N/A |
| Price to 5YR AVG FCF Ratio | -40.08 | N/A |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.40% | N/A |
| ROE (TTM) | 4.61% | N/A |
| Net Profit Margin (TTM) | 1.48% | N/A |
| ROIC 5YR AVG | -1.31% | N/A |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 811.89% | 15.50% | -102.41% |
| Revenue | 4.85% | -10.89% | -5.22% |
| Net Income | 805.65% | 18.61% | -98.54% |
| Cash Flow | 853.77% | 62.26% | 16.66% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.65 | N/A |
| Quick Ratio (TTM) | 1.68 | N/A |
| D/E Ratio (TTM) | 0.10 | N/A |
| Interest Coverage (TTM) | 2.58 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 5.04 | N/A |
| LTL to 5YR AVG FCF | -6.11 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.07% | N/A |